JP Morgan Chase
AGN

JP Morgan Chase’s Allergan Inc AGN Stock Holding History

JP Morgan Chase’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-74,200
Closed -$15.8M – 4541
2014
Q4 		$15.8M Sell
74,200
-128,100
-63% -$25.5M ﹤0.01% 1623
2014
Q3 		$36M Buy
+202,300
New +$33.6M 0.01% 1091

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

JP Morgan Chase's AGN Position: Q1 2015 in Review

JP Morgan Chase sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,942,623 shares — an estimated $413M sold.

JP Morgan Chase first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $508M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • JP Morgan Chase reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • JP Morgan Chase sold 1,942,623 Allergan Inc shares in Q1 2015, an estimated $413M.
  • JP Morgan Chase first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • JP Morgan Chase's Allergan Inc position peaked at $508M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on JP Morgan Chase's 13F filing for Q1 2015, filed 15 May 2015.